Human coronavirus SARS-CoV-2 spike glycoprotein peptide (ab273063)
Key features and details
- Suitable for: Blocking
Product nameHuman coronavirus SARS-CoV-2 spike glycoprotein peptide
See all SARS-CoV-2 spike glycoprotein proteins and peptides
Additional sequence information(C terminal). 20 amino acid peptide within the last 50 amino acids of the SARS CoV-2 spike glycoprotein
Our Abpromise guarantee covers the use of ab273063 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Blocking - Blocking peptide for Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus (ab272504)
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Store at -20°C.
Preservative: 0.02% Sodium azide
Constituents: PBS, 0.1% BSA
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
ab273063 has been referenced in 1 publication.
- Zhang YH et al. Thymosin-a1 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia. Front Biosci (Landmark Ed) 27:48 (2022). PubMed: 35226991